Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Stephen Miran Resigns as White House Economic Adviser Amid Federal Reserve Tenure 
Asian Currencies Trade Sideways as Dollar Stabilizes, Yen Weakens Ahead of Japan Election 
Trump Extends AGOA Trade Program for Africa Through 2026, Supporting Jobs and U.S.-Africa Trade 
Gold, Silver, and Platinum Rally as Precious Metals Recover from Sharp Selloff 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Oil Prices Climb as Middle East Tensions and U.S. Inventory Data Boost Market Sentiment 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
China Services PMI Hits Three-Month High as New Orders and Hiring Improve 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Asian Currencies Strengthen as Indian Rupee and Australian Dollar Rally 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Lotte Biologics unveiled a landmark $3 billion partnership with Incheon's city government, Lotte Corporation, and Incheon Free Economic Zone (IFEZ) to establish major biotech production plants in Songdo. This monumental move accelerates the biotech giant's ambitious aim of a combined production capacity of 360,000 liters by 2030.
Lotte Biologics said on Tuesday, June 20, that the MOU is its first step into building the facilities in the region. As per Korea Joongang Daily, the other parties in the project are Lotte Corporation and the Incheon Free Economic Zone (IFEZ).
The contract signing ceremony was held at the IFEZ HQ in Songdo, and executives of the companies were present, including Lotte Biologics’ CEO, Richard Lee; IFEZ’s commissioner, Kim Jin Young; Lotte Corp. president, Lee Hun Ki; and Mayor of Incheon Metropolitan City, Yoo Jeong Bok.
The construction of the production facilities is part of the biotech firm’s plan to erect three new factories that will have a combined production facility of 360,000 liters by the year 2030. The plan was first unveiled in January this year.
The industrial complex will also be a place where the start-up, Bio-Venture Initiative, is expected to open a plant and facilitate possible technological cooperation. Lotte Biologics is planning a groundbreaking event for the construction, and this may happen soon.
This agreement highlights the enthusiastic response from Incheon Metropolitan City and Incheon Free Economic Zone regarding LOTTE BIOLOGICS’ intention to establish a major presence in Songdo,” Lotte Biologic’s chief executive officer said in a press release. “With the goal of commencing construction on the Mega Plant within the year, LOTTE BIOLOGICS will actively cooperate with Incheon Metropolitan City and Incheon Free Economic Zone to swiftly facilitate a land purchase agreement, with the enthusiastic support of LOTTE Corporation.”
Photo by: Lotte Biologics Newsroom
